ALGN and the illusion of the 'cheap' growth multiple
We need to talk about the psychological trap of catching falling knives in mature growth stories, and I want to use Align Technology ($ALGN) as the punching bag. It wrapped up the session at 155.17, sliding nearly three percent on the day after bouncing around a fairly wide 154.61 to 162.17 intraday range. I keep seeing retail desks trying to build a long-term case here on the basis that the valuation has compressed to historic lows and the consumer headwind is 'priced in.' But looking at the price action over the last few quarters, the market isn't treating this as a temporary macro dip; it is pricing in systemic margin erosion and a permanent loss of pricing power to cheaper competitors. If you are timing this based on pure technical support levels, you are fighting a structural shift with a ruler and a crayon. I still think the fair value is a long staircase down from here, even if the multiple looks cheap relative to 2021's insanity. Tell me why I am wrong on the terminal growth rate assumptions here—push back, because I am tempted to short the next dead cat bounce.
The retail crowd always mistakes a broken growth story for a value play. ALGN is bleeding market share to cheaper direct-to-consumer alternatives, so that 'cheap' multiple is actually just the market correctly repricing their shrinking moat.